Target-focused pharmacophore modeling

webinar

Tue, 24 Apr 2018, 16:00 CEST (Berlin)

Prof. Dr. Andrea Volkamer, Charité

Target-focused pharmacophore modeling

Various computational tools and molecular modeling platforms are known to support medicinal chemists in understanding bioactivities, predicting binding events and rationally designing drug molecules. Among them, the pharmacophore approach is an accurate and minimal 3D-abstraction of chemical structures and intermolecular interactions.

Pharmacophore models are usually derived from a group of molecules in absence of structural information on their biological targets (ligand-based approach) or from a ligand-target complex (structure-based approach). However, only a limited amount of solutions exists to model comprehensive pharmacophores using the information of a particular target structure without knowledge of any binding ligand. In the presented work, T2F-Pharm, a fully automated tool for Truly Target-Focused Pharmacophore modeling will be introduced. Using a grid-based approach, this method samples the protein cavity, filters the grid points by energy level and clusters them into low energy hot spots. Subsequently, key features in the pocket required for optimal interaction in a 3D-pharmacophore model are derived.

T2F-Pharm represents a valuable instrument for drug discovery to investigate protein surfaces in absence of known binding partners, e.g. in cases of rather unexplored binding sites including allosteric pockets.

Current news

category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on
BioSolveIT wrapped 2025
December 15, 2025 06:18 CET
Our Year in Drug Discovery In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere. This year saw the...
Read on
category
Challenge
Emina Yekt Yilmaz Wins Scientific Challenge Winter 2024!
December 9, 2025 14:52 CET
It is our greatest pleasure to announce the winner of the Winter 2024 edition of the Scientific Challenge: the winner is Emine Yekta Yilmaz from Haceteppe and Gazi Universities (Ankara, Turkey) with her project ‘Leveraging AI and Physics-Based Screening for the Identification of sEH Inhibitors’. Based on standardized compound datasets...
Read on